ABN AMRO Bank N.V.
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1561082
AMSTERDAM, P7
Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$422,760
-$101,089 QoQ
Shares Held
678
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#847
of 1,322 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ABN AMRO Bank N.V. holds $64,116,396 across 3 Biotechnology names. REGN ranks #3 (0.7% of the industry book) .
All Filings in REGN
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $422,760 | 678 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $523,849 | 678 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $526,415 | 682 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $445,880 | 793 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $479,850 | 914 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $140,471,163 | 221,483 | Shares | Sole | 2025-08-28 | |
| 2024-12-31 | $156,619,284 | 219,869 | Shares | Sole | 2025-08-28 | |
| 2024-09-30 | $224,567,991 | 213,622 | Shares | Sole | 2025-08-28 | |
| 2024-06-30 | $215,737,570 | 205,263 | Shares | Sole | 2025-08-28 | |
| 2024-03-31 | $191,448,885 | 198,910 | Shares | Sole | 2025-08-28 | |
| 2023-12-31 | $14,764,933 | 16,811 | Shares | Sole | 2025-08-28 | |
| 2023-09-30 | $14,033,113 | 17,052 | Shares | Sole | 2025-08-28 | |
| 2023-06-30 | $638,063 | 888 | Shares | Sole | 2025-08-28 | |
| No filing history on record for this holder in this stock. | ||||||